Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAN-DOSE: Augmented NRT for Dual Users
NCT06087328Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2023
- Primary completion
- Nov 2024
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine patch in nicotine dependence, sponsored by Medical University of South Carolina. Started Dec 2023; status: completed.
02
Drugs
nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT06087328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06087328.